Mike Blecker
YOU?
Author Swipe
View article: Use of Natural Language Processing to Identify Myeloid/Lymphoid Neoplasm Patients with Fibroblast Growth Factor Receptor 1 Alterations
Use of Natural Language Processing to Identify Myeloid/Lymphoid Neoplasm Patients with Fibroblast Growth Factor Receptor 1 Alterations Open
Background : Myeloid/lymphoid neoplasms (MLN) with fibroblast growth factor receptor 1 (FGFR1) rearrangement are rare hematologic neoplasms with heterogeneous presentation and a poor prognosis. Pemigatinib, a potent, selective inhibitor of…
View article: Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US Open
Background Pemigatinib demonstrated efficacy in fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA) in the FIGHT-202 trial. However, limited real-world evidence exists on treatment patterns and outcomes in this settin…